Molgramostim

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim
Drug Alias Name先特能莫拉司亭粒细胞-巨噬细胞jiLeucomaxSCH-39300 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsGraft vs Host DiseaseAgranulocytosisHematologic Diseases +[9] 
Global Approved IndicationsAgranulocytosis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date1991/01/01
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer IncNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSchering - Plough Sa
Inactive CompaniesUniversity Of California San FranciscoUniversity Of MichiganNational Cancer Institute +[5] 
Active IndicationsAgranulocytosis
Inactive IndicationsGraft vs Host DiseaseHematologic DiseasesRespiratory Distress Syndrome, Adult +[8] 

Other Information

ATC CodeL03AA03
Related LinksN/A